avrg: GFI1 WT vs 36n/n vs KD
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Gfi1b | mm39_v1_chr2_-_28511941_28511994 | 0.42 | 4.8e-01 | Click! |
Gfi1 | mm39_v1_chr5_-_107873883_107873905 | 0.05 | 9.4e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr13_+_23947641 Show fit | 5.89 |
ENSMUST00000055770.4
|
H1.1 linker histone, cluster member |
|
chr13_-_23946359 Show fit | 5.69 |
ENSMUST00000091701.3
|
H3 clustered histone 1 |
|
chr13_-_23806530 Show fit | 3.57 |
ENSMUST00000062045.4
|
H1.4 linker histone, cluster member |
|
chr13_+_23755551 Show fit | 3.33 |
ENSMUST00000079251.8
|
H2B clustered histone 8 |
|
chr13_+_21901791 Show fit | 2.18 |
ENSMUST00000188775.2
|
H3 clustered histone 10 |
|
chr13_-_23755374 Show fit | 2.11 |
ENSMUST00000102969.6
|
H2A clustered histone 8 |
|
chr3_+_54268523 Show fit | 1.59 |
ENSMUST00000117373.8
ENSMUST00000107985.10 ENSMUST00000073012.13 ENSMUST00000081564.13 |
periostin, osteoblast specific factor |
|
chr13_-_21967540 Show fit | 1.44 |
ENSMUST00000189457.2
|
H3 clustered histone 11 |
|
chr12_-_99529767 Show fit | 1.32 |
ENSMUST00000176928.3
ENSMUST00000223484.2 |
forkhead box N3 |
|
chr7_+_24408662 Show fit | 1.25 |
ENSMUST00000206826.2
ENSMUST00000051714.9 |
Ly6/PLAUR domain containing 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.8 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.4 | 1.6 | GO:1904207 | regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.2 | 1.6 | GO:0045919 | positive regulation of cytolysis(GO:0045919) |
0.0 | 1.4 | GO:0001523 | retinoid metabolic process(GO:0001523) |
0.0 | 1.1 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.1 | 0.8 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
0.1 | 0.8 | GO:0007527 | adult somatic muscle development(GO:0007527) |
0.1 | 0.8 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.1 | 0.8 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.1 | 0.8 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 1.8 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.3 | 0.8 | GO:0002944 | cyclin K-CDK12 complex(GO:0002944) cyclin K-CDK13 complex(GO:0002945) |
0.0 | 0.8 | GO:0031527 | filopodium membrane(GO:0031527) |
0.1 | 0.7 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.7 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.6 | GO:0005614 | interstitial matrix(GO:0005614) |
0.0 | 0.5 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.0 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 1.6 | GO:0001851 | complement component C3b binding(GO:0001851) |
0.0 | 1.5 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 1.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 1.1 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 1.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.0 | 0.9 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.7 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.7 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.6 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.0 | 0.6 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.3 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.0 | 0.2 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.1 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 1.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.0 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.7 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.5 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.4 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.4 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.1 | 0.3 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |